AstraZeneca (AZN) changes key management roles in China as the company emerges from several scandals involving its executives ...

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmaceutical companies in the world.

Healthcare company AstraZeneca provides investors with a dividend that yields 2.2%. That's higher than the S&P 500 average of 1.3%. While the business possesses a diverse, robust portfolio with ...

AstraZeneca (AZN) stock in focus as the U.S. FDA expands approval for its lymphoma therapy Calquence with chemoimmunotherapy ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and granted Priority Review in ...

Moody National Bank Trust Division boosted its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 20.0% during ...

If you suffered substantial losses and wish to serve as lead plaintiff of the AstraZeneca class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or ...

The company highlighted significant milestones achieved in 2024, including collaborations with major oncology partners such as the National Cancer Institute, AstraZeneca, and Merck, which may ...

AstraZeneca and Merck Commenced enrollment and dosing in DURIPANC Phase 1b/2 study combining Ampligen with AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) for the ...

AstraZeneca. “This Priority Review, and the previously granted Breakthrough Therapy Designation, recognize the potential for datopotamab deruxtecan to provide a much-needed option to patients ...

Hagens Berman has opened an investigation into the allegations and urges investors in AstraZeneca American Depositary Shares who suffered substantial losses to submit your losses now. Class Period: ...